Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: Long-term follow-up

Surgery

Volumn 148, Issue 6, 2010, Pages 1288-1293

  Akyildiz, Hizir Yakup ^a   Mitchell, Jamie ^a   Milas, Mira ^a   Siperstein, Allan ^a   Berber, Eren ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; STREPTOZOCIN;

ABLATION THERAPY; ADULT; ARTICLE; CARCINOID; CHEMOEMBOLIZATION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPIC RADIOFREQUENCY THERMAL ABLATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MORTALITY; NEUROENDOCRINE HEPATIC METASTASIS; PANCREAS ISLET CELL CARCINOMA; PRIORITY JOURNAL; SEX DIFFERENCE; SYMPTOM; THYROID MEDULLARY CARCINOMA; TUMOR RECURRENCE; TUMOR VOLUME;

CARCINOID TUMOR; CARCINOMA, ISLET CELL; CARCINOMA, NEUROENDOCRINE; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIO WAVES; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SURVIVAL RATE; THYROID NEOPLASMS; TIME FACTORS;

EID: 78649927347     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.09.014     Document Type: Article

References (23)

1. A.E. Siperstein, and E. Berber Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases World J Surg 25 2001 693 696
2. E. Berber, N. Flesher, and A.E. Siperstein Laparoscopic radiofrequency ablation of neuroendocrine liver metastases World J Surg 26 2002 985 990
3. K. Oberg The use of chemotherapy in the management of neuroendocrine tumors Endocrinol Metab Clin North Am 22 1993 941 952 (Pubitemid 24017279)
4. A. Rinke, H.H. Müller, C. Schade-Brittinger, K.J. Klose, P. Barth, M. Wied PROMID Study Group Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group J Clin Oncol 27 2009 4656 4663
5. A.E. Siperstein, S.J. Rogers, P.D. Hansen, and A. Gitomirsky Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases Surgery 122 1997 1147 1154
6. P.J. Mazzaglia, E. Berber, M. Milas, and A.E. Siperstein Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival Surgery 142 2007 10 19
7. R. Arnold, A. Rinke, K.J. Klose, H.H. Müller, M. Wied, and K. Zamzow Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial Clin Gastroenterol Hepatol 3 2005 761 771
8. A.J. Bilchik, T. Sarantou, L.J. Foshag, A.E. Giuliano, and K.P. Ramming Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy Surgery 122 1997 1040 1047
9. J.K. Seifert, T. Junginger, and D.L. Morris A collective review of the world literature on hepatic cryotherapy J R Coll Surg Edinb 43 1998 141 154
10. L.J. Perry, K. Stuart, K.R. Stokes, and M.E. Clouse Hepatic arterial chemoembolization for metastatic neuroendocrine tumors Surgery 116 1994 111 116
11. D. O'Toole, and P. Ruszniewski Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours Best Pract Res Clin Gastroenterol 19 2005 585 594
12. E. Berber, and A. Siperstein Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors Ann surg Oncol 14 2008 2757 2764
13. J.G. Touzios, J.M. Kiely, S.C. Pitt, W.S. Rilling, E.J. Quebbeman, and S.D. Wilson Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241 2005 776 783
14. E.T. Janson, and K. Oberg Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon Acta Oncol 32 1993 225 229
15. P. Ruszniewski, M. Ducreux, J.A. Chayviall, J. Blumberg, D. Cloarec, and H. Michel Treatment of the carcinoid syndrome with the long acting somatostatin analogue lantreotide: a prospective study in 39 patients Gut 39 1996 279 283
16. C.H. Carrasco, C. Charnsangavej, J. Ajani, N.A. Samaan, W. Richli, and S. Wallace The carcinoid syndrome: palliation by hepatic artery embolization AJR Am J Roentgenol 147 1986 149 154
17. S. Gupta, M.M. Johnson, R. Murthy, K. Ahrar, M.J. Wallace, and D.C. Madoff Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival Cancer 104 2005 1007 1009
18. R. Adam, E.J. Hagopian, M. Linhares, J. Krissat, E. Savier, and D. Azoulay A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies Arch Surg 137 2002 1332 1339
19. M. Kalinowski, M. Dressler, A. König, M. El-Sheik, A. Rinke, and H. Höffken Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study Digestion 79 2009 137 142
20. Raymond E, Niccoli-Sire P, Bang Y, Borbath I, Lombard-Bohas C, Valle JW, et al. Updated results of the phase III trial of Sunitinib versus placebo for treatment of advanced neuroendocrine tumors. 2010 ASCO Gastrointestinal Cancer Symposium, Abstract no.127
21. J.M. Sarmiento, G. Heywood, J. Rubin, D.M. Ilstrup, D.M. Nagorney, and F.G. Que Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival J Am Coll Surg 197 2003 29 37
22. Y.P. Le Treut, J.R. Delpero, B. Dousset, D. Cherqui, P. Segol, and G. Mantion Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report Ann Surg 225 1997 355 364
23. G.A. Kaltsas, J.J. Mukherjee, A. Isidori, B. Kola, P.N. Plowman, and J.P. Monson Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil Clin Endocrinol 57 2002 169 183